$STOK
Stoke Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$28.43
▼-1.73%-$0.500
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateStoke Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is STOK down today? It is at $28.43 (-1.73%), and our scanner flagged it 62 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment STOK spikes, and full due diligence on STOK — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $STOK 62 times in the last 30 days. Create a free account to track $STOK, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on STOK from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for STOK today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystPriced share offering, from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Sep 3, 2026 · 16 days agoThe company can keep selling new shares into the market. Size not stated in the filing.
Some filings did not state a size, so these are floors.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
6,930,007 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time · About $200.0M in size · Priced at $28.86/share
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Ticho Barry Officer | Sold (automatic/other) | -6K | sold 22% | 20K | $169K at $30.51 | Sep 1, 26 |
Allan Jonathan Officer | Sold (automatic/other) | -3K | sold 12% | 21K | $92K at $32.01 | Aug 18, 26 |
Kaye Edward M. Md Director | Sold (automatic/other) | -13K 0.02% of company | sold 9.2% | 125K | $402K at $32.01 | Aug 18, 26 |
Ticho Barry Officer | Sold (automatic/other) | -5K | sold 16% | 26K | $153K at $32.01 | Aug 18, 26 |
Allan Jonathan Officer | Other | 6K | added 33% | 24K | n/a | Aug 14, 26 |
Kaye Edward M. Md Director | Other | 26K 0.04% of company | added 24% | 137K | n/a | Aug 14, 26 |
Ticho Barry Officer | Other | 10K 0.02% of company | added 49% | 30K | n/a | Aug 14, 26 |
Ticho Barry Officer | Sold (automatic/other) | -7K 0.01% of company | sold 26% | 20K | $208K at $28.95 | Aug 3, 26 |
Ticho Barry Officer | Sold (automatic/other) | -7K 0.01% of company | sold 21% | 28K | $236K at $32.62 | Jul 1, 26 |
Allan Jonathan Officer | Sold (automatic/other) | -1K | sold 7.5% | 18K | $44K at $29.95 | Jun 16, 26 |
Ticho Barry Officer | Sold (automatic/other) | -2K | sold 4.9% | 35K | $55K at $30.58 | Jun 1, 26 |
Ticho Barry Officer | Sold (automatic/other) | -2K | sold 5.8% | 37K | $74K at $32.79 | May 1, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on STOK from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for STOK today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
STOK last traded at $28.43, down 1.73% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Stoke Therapeutics, Inc. Common Stock (STOK) is next expected to report earnings on Tuesday, November 3, 2026, about 44 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The STOK Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged STOK 62 times in the last 30 days.
STOK (Stoke Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $1.83B in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge STOK for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$STOK discussion
Sign in to ask a question or join the discussion.